FluoGuide A/S (STO:FLUO)
31.40
-0.60 (-1.88%)
Aug 13, 2026, 5:22 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 523.18 million as of August 13, 2026. Its market cap has decreased by -7.88% in one year.
Market Cap
523.18M
Enterprise Value
471.33M
Revenue
349.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
31.40
ChartMarket Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 523.18M, an increase of 1,207.21%. That is a compound annual growth rate of 42.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 523.18M | -6.71% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 1.05B |
| AlzeCure Pharma AB | 926.67M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 654.35M |
| Oncopeptides AB | 628.51M |
| Corline Biomedical AB | 466.48M |
| Cantargia AB | 454.96M |
| Mendus AB | 412.97M |